Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Cervical cancer screening rates climbed across all racial and ethnic groups between 2019 and 2024, with Hispanic patients seeing the biggest jump. But American Indian, Alaska Native, Native Hawaiian, and Pacific Islander women consistently had the lowest rates, and patients in Western and Southern regions also lagged behind. Progress is real — but the gaps still need serious attention.
Good news with an asterisk: cervical cancer screening (CCS) rates rose across all racial and ethnic groups from 2019 to 2024, according to a large retrospective study published in JAMA Network Open. The analysis drew on data from 9–16 million female patients aged 21–64 per year, tracked through electronic medical records across more than 1,800 hospitals nationwide.
Hispanic patients led the charge with the largest percentage gain, while non-Hispanic White patients — who started with the highest rates — saw the smallest increase. Meanwhile, American Indian, Alaska Native, Native Hawaiian, and Pacific Islander patients consistently ranked at the bottom throughout the entire study period, and patients in Western and Southern census regions also trailed their counterparts elsewhere.
By the Numbers:
Why it matters: Rising screening rates are a win, but persistent geographic and racial disparities mean certain populations remain at disproportionate risk for late-stage cervical cancer diagnoses. Targeted outreach and policy interventions — especially in underserved communities and underperforming regions — are essential to close these gaps.
